Particularly in hepatocytes, the overexpression of FoxO1 induces the accumulation of triglycerides [39], and targeting the FoxO1 expression in mouse livers may contribute to reversed metabolic syndrome [40]. This evidence concerns the gene FOXO1 and metabolic syndrome.